Lecat S - Search Results

1

Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes.

Delaitre C, Boisbrun M, Lecat S, Dupuis F. Delaitre C, et al. Among authors: lecat s. Int J Mol Sci. 2021 Jun 23;22(13):6738. doi: 10.3390/ijms22136738. Int J Mol Sci. 2021. PMID: 34201646 Free PMC article. Review.

2

No answer to the lack of specificity: mouse monoclonal antibody targeting the angiotensin II type 1 receptor AT₁ fails to recognize its target.

Bouressam ML, Lartaud I, Dupuis F, Lecat S. Bouressam ML, et al. Among authors: lecat s. Naunyn Schmiedebergs Arch Pharmacol. 2018 Aug;391(8):883-889. doi: 10.1007/s00210-018-1522-4. Epub 2018 Jun 4. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 29868927

3

S-nitrosoglutathione inhibits cerebrovascular angiotensin II-dependent and -independent AT₁ receptor responses: A possible role of S-nitrosation.

Bouressam ML, Lecat S, Raoul A, Gaucher C, Perrin-Sarrado C, Lartaud I, Dupuis F. Bouressam ML, et al. Among authors: lecat s. Br J Pharmacol. 2019 Jun;176(12):2049-2062. doi: 10.1111/bph.14644. Epub 2019 May 7. Br J Pharmacol. 2019. PMID: 30822355 Free PMC article.

4

Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.

Lecat S, Belemnaba L, Galzi JL, Bucher B. Lecat S, et al. Cell Signal. 2015 Jul;27(7):1297-304. doi: 10.1016/j.cellsig.2015.03.016. Epub 2015 Mar 25. Cell Signal. 2015. PMID: 25817573

5

Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

Galzi JL, Hachet-Haas M, Bonnet D, Daubeuf F, Lecat S, Hibert M, Haiech J, Frossard N. Galzi JL, et al. Among authors: lecat s. Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1. Pharmacol Ther. 2010. PMID: 20117133 Free PMC article. Review.

6

GPRASP/ARMCX Protein Family: Potential Involvement in Health and Diseases Revealed by their Novel Interacting Partners.

Kaeffer J, Zeder-Lutz G, Simonin F, Lecat S. Kaeffer J, et al. Among authors: lecat s. Curr Top Med Chem. 2021;21(3):227-254. doi: 10.2174/1568026620666201202102448. Curr Top Med Chem. 2021. PMID: 33267763 Review.

7

A Fluorescent Live Imaging Screening Assay Based on Translocation Criteria Identifies Novel Cytoplasmic Proteins Implicated in G Protein-coupled Receptor Signaling Pathways.

Lecat S, Matthes HW, Pepperkok R, Simpson JC, Galzi JL. Lecat S, et al. Mol Cell Proteomics. 2015 May;14(5):1385-99. doi: 10.1074/mcp.M114.046698. Epub 2015 Mar 10. Mol Cell Proteomics. 2015. PMID: 25759509 Free PMC article.

8

Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors.

Perret BG, Wagner R, Lecat S, Brillet K, Rabut G, Bucher B, Pattus F. Perret BG, et al. Among authors: lecat s. Protein Expr Purif. 2003 Sep;31(1):123-32. doi: 10.1016/s1046-5928(03)00140-2. Protein Expr Purif. 2003. PMID: 12963349

9

Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.

Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mély Y, Takeda K, Bucher B, Galzi JL. Gicquiaux H, et al. Among authors: lecat s. J Biol Chem. 2002 Feb 22;277(8):6645-55. doi: 10.1074/jbc.M107224200. Epub 2001 Dec 7. J Biol Chem. 2002. PMID: 11741903 Free article.

10

Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses.

Lecat S, Bucher B, Mely Y, Galzi JL. Lecat S, et al. J Biol Chem. 2002 Nov 1;277(44):42034-48. doi: 10.1074/jbc.M203606200. Epub 2002 Aug 15. J Biol Chem. 2002. PMID: 12185075 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters